Claremont Biosolutions
The test detects a signature molecular marker upregulated by viable bacteria, and will be useful for pediatric, extrapulmonary, and AIDS-related TB.
IncellDx Inks Exclusive Licensing Deal with Claremont BioSolutions
The partners will couple Claremont BioSolutions' enzyme-free tissue homogenization technology with IncellDx's reagents.
Keck Graduate Institute-led Team Begins New NIH Grant to Develop Point-of-Care Tuberculosis MDx
Premium
NEW YORK (GenomeWeb) — A public-private team led by researchers at the Keck Graduate Institute of Life Sciences has been awarded just over $600,000 by the National Institutes of Health for the first year of a four-year project to further develop its point-of-care nucleic acid testing platform for
In-Q-Tel Invests in Claremont to Accelerate Sample Prep Platform
NEW YORK (GenomeWeb News) – Claremont BioSolutions said today it has entered a strategic partnership with investment firm In-Q-Tel to accelerate commercialization of Claremont's Prep-on-a-Chip sample preparation platform.
Claremont BioSolutions Moves into Europe, Taiwan, S. Korea with Distribution Deals
NEW YORK (GenomeWeb News) – Molecular diagnostics products firm Claremont BioSolutions has signed deals to distribute its products in Europe, Taiwan, and South Korea.
Dec 8, 2011
Nov 11, 2010